The Impact of Pharmacogenomic CYP3A5 Variants on Calcineurin Inhibitor Metabolism and SLCO1B1 Variants on Methotrexate in Adult Allogeneic BMT Patients
- Resource Type
- Article
- Source
- In
Transplantation Reports December 2022 7(4) - Subject
- Language
- ISSN
- 2451-9596